{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:55:00Z","timestamp":1785772500089,"version":"3.56.0"},"reference-count":20,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Psychiatry in Clinical Practice"],"published-print":{"date-parts":[[1998,1,1]]},"DOI":"10.3109\/13651509809115369","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T17:46:15Z","timestamp":1203097575000},"page":"251-254","source":"Crossref","is-referenced-by-count":6,"title":["Combination therapy with nefazodone and lithium: Safety and tolerability in fourteen patients"],"prefix":"10.1080","volume":"2","author":[{"given":"Christopher","family":"Hawley","sequence":"first","affiliation":[{"name":"Mood Disorders Clinic, Queen Elizabeth II Hospital","place":["Welwyn Garden City, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanusha","family":"Sivakumaran","sequence":"additional","affiliation":[{"name":"Hertfordshire Neuroscience Research Group, University of Hertfordshire","place":["Hatfield, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Huber","sequence":"additional","affiliation":[{"name":"Mood Disorders Clinic, Queen Elizabeth II Hospital","place":["Welwyn Garden City, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi Kolade","family":"Ige","sequence":"additional","affiliation":[{"name":"Mood Disorders Clinic, Queen Elizabeth II Hospital","place":["Welwyn Garden City, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.159.4.510"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820170065008"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.162.5.634"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.166.1.80"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245291"},{"key":"e_1_2_1_7_1","article-title":"Fluvoxamine and fluoxetine\u2014interaction with monoamine oxidase inhibitors, lithium and tryptophan","volume":"26","author":"Committee on Safety of Medicines (1989)","unstructured":"Committee on Safety of Medicines (1989). Fluvoxamine and fluoxetine\u2014interaction with monoamine oxidase inhibitors, lithium and tryptophan. Current Problems, 26","journal-title":"Current Problems"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.6.705"},{"key":"e_1_2_1_9_1","first-page":"A21","article-title":"Toxic Serotonin Syndrome (TSS): An update and revised diagnosis criteria","volume":"1","author":"Radomski J W","year":"1995","unstructured":"Radomski J W, Dursun S M, Reveley M A. Toxic Serotonin Syndrome (TSS): An update and revised diagnosis criteria. J Psychopharmacology 1995; 1(suppl)A21, (84).","journal-title":"J Psychopharmacology"},{"key":"e_1_2_1_10_1","first-page":"69","article-title":"The combined use of lithium and SSRIs","volume":"2","author":"Bauer M.","year":"1995","unstructured":"Bauer M. The combined use of lithium and SSRIs. J Serotonin Res 1995; 2: 69\u201376","journal-title":"J Serotonin Res"},{"key":"e_1_2_1_11_1","first-page":"465","article-title":"Selective 5HT receptor blockade: pharmacologic studies of BMY13754, a non tricyclic antidepressant candidate","volume":"8","author":"Taylor D P","year":"1982","unstructured":"Taylor D P, Eison M S, Riblet L A, et al. Selective 5HT receptor blockade: pharmacologic studies of BMY13754, a non tricyclic antidepressant candidate. Soc Neurosci Abstr 1982; 8: 465","journal-title":"Soc Neurosci Abstr"},{"issue":"1","key":"e_1_2_1_12_1","first-page":"26","article-title":"Effect of nefazodone and lithium on sleep architecture in healthy men","volume":"10","author":"Sharpley A L","year":"1996","unstructured":"Sharpley A L, Walsh A ES, Cowen P J. Effect of nefazodone and lithium on sleep architecture in healthy men. J Psychopharmacol 1996; 10(suppl 1)26\u201329","journal-title":"J Psychopharmacol"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"e_1_2_1_14_1","volume-title":"Assessment Manual for Psychopharmacology","author":"Guy W.","year":"1976","unstructured":"Guy W. Early Clinical Drug Evaluation (ECDEU). Assessment Manual for Psychopharmacology. National Institute of Mental Health, Rockville, MD. 1976"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119400800412"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199400910-00005"},{"key":"e_1_2_1_17_1","first-page":"510","article-title":"Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study. 1. Austin MPV, Souza FGM, Goodwin GM (1991) Lithium augmentation in antidepressant resistant patients. A quantitative analysis","volume":"159","author":"Dinan T G.","year":"1993","unstructured":"Dinan T G. Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study. 1. Austin MPV, Souza FGM, Goodwin GM (1991) Lithium augmentation in antidepressant resistant patients. A quantitative analysis. Br J Psychiatry 1993; 159: 510\u20134","journal-title":"Br J Psychiatry"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820170065008"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.162.5.634"},{"key":"e_1_2_1_20_1","first-page":"300","article-title":"Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine","volume":"88","author":"Katona C L","year":"1995","unstructured":"Katona C L, Abou-Saleh M, Harrison D A, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry Scand 1995; 88: 300\u20131","journal-title":"Br J Psychiatry Scand"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119601000311"}],"container-title":["International Journal of Psychiatry in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/13651509809115369","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/13651509809115369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:12:03Z","timestamp":1785769923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/13651509809115369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,1,1]]}},"alternative-id":["10.3109\/13651509809115369"],"URL":"https:\/\/doi.org\/10.3109\/13651509809115369","relation":{},"ISSN":["1365-1501","1471-1788"],"issn-type":[{"value":"1365-1501","type":"print"},{"value":"1471-1788","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1,1]]}}}